A Significant Market Opportunity
Recent vaccine license and transaction deals show the growing demand for late stage emerging and specialist vaccines amongst the leading pharmaceutical companies.
The global vaccine market is currently estimated at 14 Billion USD*, with growth perspectives well into the two-digit range. Vaccines are worldwide used to prevent infectious diseases and new products are regularly introduced, with hundreds of millions of inoculations annually. Though there are lots of vaccines available, the number of life-threatening or severely debilitating diseases with no effective vaccine for prevention and/or treatment is still considerable high.